BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33646306)

  • 41. A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin.
    Wang Y; Zolotarev N; Yang CY; Rambold A; Mittler G; Grosschedl R
    Immunity; 2020 Dec; 53(6):1151-1167.e6. PubMed ID: 33159853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
    Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
    Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Schieck M; Lentes J; Thomay K; Hofmann W; Behrens YL; Hagedorn M; Ebersold J; Davenport CF; Fazio G; Möricke A; Buchmann S; Alten J; Cario G; Schrappe M; Bergmann AK; Stanulla M; Steinemann D; Schlegelberger B; Cazzaniga G; Göhring G
    Ann Hematol; 2020 Apr; 99(4):809-818. PubMed ID: 32078009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
    Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
    Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
    Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
    Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
    Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genes and childhood leukemia.
    Kęsy J; Januszkiewicz-Lewandowska D
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():302-8. PubMed ID: 25748621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
    Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia.
    Wang C; Li L; Li M; Shen X; Liu Y; Wang S
    Exp Cell Res; 2021 Jan; 398(1):112371. PubMed ID: 33188849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.
    Tharkar-Promod S; Johnson DP; Bennett SE; Dennis EM; Banowsky BG; Jones SS; Shearstone JR; Quayle SN; Min C; Jarpe M; Mosbruger T; Pomicter AD; Miles RR; Chen WY; Bhalla KN; Zweidler-McKay PA; Shrieve DC; Deininger MW; Chandrasekharan MB; Bhaskara S
    Leukemia; 2018 Jan; 32(1):49-60. PubMed ID: 28579617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.
    Iqbal Z; Akhtar T; Awan T; Aleem A; Sabir N; Rasool M; Absar M; Akram AM; Shammas MA; Shah IH; Khalid M; Taj AS; Jameel A; Alanazi A; Gill AT; Hashmi JA; Hussain A; Sabar MF; Khalid AM; Qazi MH; Karim S; Siddiqi MH; Mahmood A; Iqbal M; Saeed A; Irfan MI
    Mol Diagn Ther; 2015 Oct; 19(5):277-87. PubMed ID: 26266519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Leyva-Vázquez MA
    Oncol Rep; 2016 Sep; 36(3):1226-32. PubMed ID: 27431573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment.
    Ramírez J; Lukin K; Hagman J
    Curr Opin Immunol; 2010 Apr; 22(2):177-84. PubMed ID: 20207529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
    Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.
    Paulsson K; Cazier JB; Macdougall F; Stevens J; Stasevich I; Vrcelj N; Chaplin T; Lillington DM; Lister TA; Young BD
    Proc Natl Acad Sci U S A; 2008 May; 105(18):6708-13. PubMed ID: 18458336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional dysregulation of the multifunctional zinc finger factor 423 in acute lymphoblastic leukemia of childhood.
    Harder L; Otto B; Horstmann MA
    Genom Data; 2014 Dec; 2():96-8. PubMed ID: 26484080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.
    Gleissner B; Gökbuget N; Bartram CR; Janssen B; Rieder H; Janssen JW; Fonatsch C; Heyll A; Voliotis D; Beck J; Lipp T; Munzert G; Maurer J; Hoelzer D; Thiel E;
    Blood; 2002 Mar; 99(5):1536-43. PubMed ID: 11861265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.